Devices › Suture, absorbable, synthetic, polyglycolic acid
Device brand name · Suture absorbable synthetic
Vicryl Polyglactin 910 Suture Unknown Product: medical device reports filed with FDA
2,373 reports name it, 2017–2026. Manufacturer given most often on reports: Ethicon. Product code GAM.
- 2,373
- device reports naming the brand
- 0% of all MAUDE reports · about 271 a year
- 210
- reports, 12 months to August 2026
- 410 in the 12 months before
- 6.5%
- classified as malfunction
- 76.5% across the product code
- 1.2%
- classified as death, as reported
- 29 reports · not verified by FDA
2,373 medical device reports received by FDA name the brand "Vicryl Polyglactin 910 Suture Unknown Product" (suture absorbable synthetic); the manufacturer given most often on reports is Ethicon; received from October 2017 to April 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
210 reports arrived in the 12 months to August 2026, down 49% from 410 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are injury (92.3%), malfunction (6.5%) and death (1.2%); across all suture, absorbable, synthetic, polyglycolic acid reports (product code GAM) death is recorded in 0.2% and malfunction in 76.5%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are break (3.9%), material frayed (1.8%) and material separation (1.5%). The patient problems coded most often are wound dehiscence, not applicable and pain. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 56,946 reports carrying product code GAM. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Breakthe device broke | 93 | 3.9% | 36.3% |
| Material frayed | 42 | 1.8% | 1.2% |
| Material separation | 36 | 1.5% | 18.8% |
| Material integrity problema problem with the device material | 34 | 1.4% | 1.6% |
| Insufficient device problem information | 26 | 1.1% | 1.1% |
| Device operates differently than expectedthe device behaved unexpectedly | 25 | 1.1% | 0.4% |
| Device markings/labelling problema problem with the device markings or label | 21 | 0.9% | 0.6% |
| Positioning failure | 20 | 0.8% | 0.3% |
| Patient-device incompatibilitythe device did not suit the patient | 16 | 0.7% | 1.1% |
| Dull, blunt | 9 | 0.4% | 0.3% |
| Product quality problem | 9 | 0.4% | 0.5% |
| Material erosion | 6 | 0.3% | 0% |
| Malposition of device | 4 | 0.2% | 0% |
| Material protrusion/extrusion | 4 | 0.2% | 0% |
| Compatibility problem | 3 | 0.1% | 0% |
| Contamination | 2 | 0.1% | 0.3% |
| Degraded | 2 | 0.1% | 0.1% |
| Device dislodged or dislocated | 2 | 0.1% | 0% |
| Failure to degrade | 2 | 0.1% | 0.2% |
| Failure to form staple | 2 | 0.1% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Wound dehiscencea wound reopened | 430 | 18.1% |
| Not applicable | 270 | 11.4% |
| Painpain, site not specified | 266 | 11.2% |
| Hemorrhage/blood loss/bleeding | 237 | 10% |
| Hematomaa collection of blood under the skin or in tissue | 222 | 9.4% |
| Post operative wound infection | 221 | 9.3% |
| Seromaa collection of fluid under the skin | 180 | 7.6% |
| Inflammationinflammation | 141 | 5.9% |
| Hernia | 127 | 5.4% |
| Fistula | 126 | 5.3% |
| Obstruction/occlusion | 116 | 4.9% |
| Abscessa collection of pus | 98 | 4.1% |
| Failure to anastomose | 97 | 4.1% |
| Necrosisdeath of tissue | 96 | 4% |
| Blood loss | 89 | 3.8% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | Vicryl Polyglactin 910 Suture Unknown Product | Product code GAM | All MAUDE reports |
|---|---|---|---|
| Reports | 2,373 | 56,946 | 26,136,888 |
| Share of that pool | — | 4.2% | 0% |
| Classified as death, per 1,000 reports | 12 | 2 | 9 |
| Classified as injury | 92.3% | 23% | 36.2% |
| Classified as malfunction | 6.5% | 76.5% | 62.3% |
| Filed by the manufacturer | 100% | 98% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code GAM
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Polysorb | 5,410 | 1,836 | 0% |
| V-Loc 180 | 3,447 | 678 | 0% |
| Coated VICRYL (polyglactin 910) Suture | 1,930 | 20 | 0.5% |
| Maxon | 1,809 | 309 | 0% |
| Biosyn | 1,681 | 261 | 0% |
| V-Loc 90 | 1,378 | 226 | 0% |
| VICRYL Polyglactin 910 Suture | 1,262 | 74 | 0.1% |
| Vcl+ Ud 27in 5-0 S/A Tf | 1,125 | 158 | 0.1% |
| Coated VICRYL | 978 | 851 | 0% |
| Vicryl Plus Antibacterial Polyglactin 910 Suture | 852 | 0 | 0.1% |
| Coated Vicryl Plus Antibacterial Polyglactin 910 | 724 | 0 | 0% |
| Vcl+ Ud 18in 5-0 S/A P-3 Prm Mp | 518 | 126 | 0% |
| Unknown VLoc Product | 413 | 39 | 3.6% |
| Caprosyn | 399 | 94 | 0% |
| Vcl+ Vio 36in 2-0 S/A Ct-1 | 399 | 42 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about Vicryl Polyglactin 910 Suture Unknown Product reports
How many FDA reports name Vicryl Polyglactin 910 Suture Unknown Product?
2,373 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 210 in the latest 12 months.
What kinds of events are reported?
injury (92.3%), malfunction (6.5%) and death (1.2%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
break (3.9%), material frayed (1.8%), material separation (1.5%), material integrity problem (1.4%) and insufficient device problem information (1.1%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that Vicryl Polyglactin 910 Suture Unknown Product was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.